Manasa Life Sciences supplies high-quality Active Pharmaceutical Ingredients (APIs) through a structured and compliant process designed to ensure product integrity, regulatory adherence, and customer satisfaction. The process begins with supplier qualification and raw material sourcing, where only vendors meeting stringent quality, GMP, ISO, and regulatory requirements are approved. API manufacturing is conducted in GMP-certified facilities using validated processes. Each stage of manufacturing is closely monitored to ensure consistency in identity, potency, and purity, with strict control of intermediate steps to identify and mitigate any deviations or impurities.
API identity is confirmed using advanced analytical techniques such as NMR and FT-IR, while quantitative assays, including HPLC, GC, and Q-NMR, are performed to verify potency. Comprehensive impurity profiling, microbial limit testing, and stability studies are carried out to ensure compliance with pharmacopeial standards and international regulatory guidelines. Finished APIs are packaged in tamper-evident, chemically inert containers under controlled environmental conditions. Storage is maintained at defined temperatures to preserve product stability. Each unit is clearly labeled with complete product information, recommended storage conditions, and retest or expiry dates supported by real-time and accelerated stability data.
For every batch, Manasa Life Sciences provides complete regulatory documentation, including Certificates of Analysis (CoA), Analytical Test Reports (ATR), and Material Safety Data Sheets (MSDS), ensuring full traceability and supporting regulatory submissions worldwide. All shipments are managed using validated logistics systems, with ambient, refrigerated, or frozen transportation as required. Real-time temperature monitoring ensures product quality is maintained throughout transit. We supply APIs to markets across Asia, Europe, Africa, the GCC, and the UAE, ensuring reliable delivery, full traceability, and adherence to Good Documentation Practices for Active Pharmaceutical Ingredients and finished dosage forms.
Even after delivery, our after-sales support and retest policy ensure continued product quality. Batches assigned a retest date are periodically re-evaluated using validated analytical methods, and updated Certificates of Analysis are provided when required. No product is released or supplied beyond its retest or expiry date without proper verification.
This end-to-end quality system ensures our clients receive APIs that are consistent, compliant, and ready for safe pharmaceutical use.